Salarius Pharmaceuticals (SLRX)
(Delayed Data from NSDQ)
$0.49 USD
+0.01 (2.35%)
Updated May 8, 2024 03:03 PM ET
After-Market: $0.48 -0.01 (-1.48%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 40% (97 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 1.52 | 9.99 |
Current Quarter Estimate | -6.70 | -2.04 | 57.00 |
Year Ago Quarter Estimate | -2.23 | -0.59 | 52.54 |
Next Quarter Estimate | -6.70 | -2.00 | 61.00 |
Next Year Estimate | -23.50 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -597.92 | 12.90 | 15.67 |
Next Year | 12.31 | 14.40 | 9.31 |
Last 5 Years | NA | 5.50 | 8.10 |
Next 5 Years | NA | 21.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 0.35 | 1.91 |
Price/Cash Flow (MRFY) | NA | 9.59 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | 0.82% |
Return on Equity (TTM) | -197.96% | -24.69% |
Debt to Equity (MRQ) | NA | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.